Kissei Financial Statements From 2010 to 2025
| KSPHF Stock | USD 26.97 3.31 10.93% |
Check Kissei Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kissei Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Kissei financial statements analysis is a perfect complement when working with Kissei Pharmaceutical Valuation or Volatility modules.
Kissei |
Kissei Pharmaceutical Co Company Return On Asset Analysis
Kissei Pharmaceutical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Kissei Pharmaceutical Return On Asset | -0.0017 |
Most of Kissei Pharmaceutical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kissei Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Kissei Pharmaceutical Co has a Return On Asset of -0.0017. This is 99.98% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 98.79% lower than that of the firm.
Kissei Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kissei Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Kissei Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kissei Pharmaceutical competition to find correlations between indicators driving Kissei Pharmaceutical's intrinsic value. More Info.Kissei Pharmaceutical Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kissei Pharmaceutical's earnings, one of the primary drivers of an investment's value.About Kissei Pharmaceutical Financial Statements
Kissei Pharmaceutical stakeholders use historical fundamental indicators, such as Kissei Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Kissei Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Kissei Pharmaceutical's assets and liabilities are reflected in the revenues and expenses on Kissei Pharmaceutical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Kissei Pharmaceutical Co. Please read more on our technical analysis and fundamental analysis pages.
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products primarily in Japan. The company was founded in 1946 and is headquartered in Matsumoto, Japan. Kissei Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1828 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Kissei Pink Sheet
Kissei Pharmaceutical financial ratios help investors to determine whether Kissei Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kissei with respect to the benefits of owning Kissei Pharmaceutical security.